02/05/2024
PromptCare is proud to announce we have been selected by Kedrion Biopharma Inc to dispense Coagadex, the first and only FDA-approved therapy to treat hereditary factor X deficiency and the only factor X concentrate available worldwide.
“We are thrilled to bring the PromptCare brand of high-touch service to patients with factor X deficiency. This product is a game-changer in factor X-deficient patients’ lives.” – Paul Jardina, CEO of PromptCare
Learn more: https://ow.ly/bJ8W50QxWsf
Coagadex is the first and only treatment for factor X deficiency NEW PROVIDENCE, N.J. (Feb. 5, 2024) ― PromptCare, a leader in specialty pharmacy and in-home and alternate-site infusion therapy, proudly announces that it has been selected by Kedrion Biopharma to dispense Coagadex, a limited-distri...